Net profit of Ishita Drugs & Industries declined 33.33% to Rs 0.16 crore in the quarter ended December 2025 as against Rs 0.24 crore during the previous quarter ended December 2024. Sales declined 23.97% to Rs 3.14 crore in the quarter ended December 2025 as against Rs 4.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.144.13 -24 OPM %4.787.26 - PBDT0.230.35 -34 PBT0.200.32 -38 NP0.160.24 -33 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live News

Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3.073.27 -6 OPM %5.867.03 - PBDT0.250.28 -11 PBT0.220.25 -12 NP0.140.19 -26 Powered by Capital Market - Live News

Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Ishita Drugs & Industries announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News